Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.73 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL2861891 | 0.86 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5484929 | 0.85 | TSHR (1.00) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL16267 | 0.85 | — | — | |
| Tetrylammonium SCHEMBL4078612 | 0.85 | TSHR (1.00) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2855242 | 0.84 | TSHR (0.61) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2196947 | 0.82 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL11352843 | 0.82 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL23528606 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL333139 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL863 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3330311-B1 | STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2021-05-05 | — | — | EP | claimed |
| US-10633519-B2 | Storage-stable polyurethane prepregs and mouldings produced therefrom composed of a polyurethane composition with liquid resin components | EVONIK OPERATIONS GMBH (DE) | 2020-04-28 | — | — | US | claimed |
| US-10626236-B2 | Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom | EVONIK OPERATIONS GMBH (DE) | 2020-04-21 | — | — | US | claimed |
| US-20180155515-A1 | STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM | EVONIK OPERATIONS GMBH (DE) | 2018-06-07 | — | — | US | claimed |
| EP-2411439-B1 | PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE | EVONIK DEGUSSA GMBH (DE) | 2016-11-16 | — | — | EP | claimed |
| EP-2188320-B1 | DUAL CURE FORMULATIONS WITH COMPONENTS COMPRISING URETDIONE GROUPS | EVONIK DEGUSSA GMBH (DE) | 2014-05-14 | — | — | EP | claimed |
| US-20140087613-A1 | STORAGE-STABLE POLYURETHANE PREPREGS AND MOULDINGS PRODUCED THEREFROM COMPOSED OF A POLYURETHANE COMPOSITION WITH LIQUID RESIN COMPONENTS | EVONIK DEGUSSA GMBH (DE) | 2014-03-27 | — | — | US | claimed |
| US-8455090-B2 | Prepegs and molded bodies produced thereof at low temperature | EVONIK DEGUSSA GMBH (DE) | 2013-06-04 | — | — | US | claimed |
| US-20120003890-A1 | PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE | EVONIK DEGUSSA GMBH (DE) | 2012-01-05 | — | — | US | claimed |
| US-20100227942-A1 | DUAL-CURE FORMULATIONS WITH COMPONENTS CONTAINING URETDIONE GROUPS | EVONIK DEGUSSA GMBH (DE) | 2010-09-09 | — | — | US | claimed |
| US-10793664-B2 | Process for preparing trimers and/or oligomers of diisocyanates | EVONIK OPERATIONS GMBH (DE) | 2020-10-06 | — | — | US | disclosed |
| US-10633519-B2 | Storage-stable polyurethane prepregs and mouldings produced therefrom composed of a polyurethane composition with liquid resin components | EVONIK OPERATIONS GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| US-10626236-B2 | Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom | EVONIK OPERATIONS GMBH (DE) | 2020-04-21 | — | — | US | disclosed |
| US-10336856-B2 | Alkoxysilane- and allophanate-functionalized coating materials | EVONIK DEGUSSA GMBH (DE) | 2019-07-02 | — | — | US | disclosed |
| US-20180327538-A1 | PROCESS FOR PREPARING TRIMERS AND/OR OLIGOMERS OF DIISOCYANATES | EVONIK OPERATIONS GMBH (DE) | 2018-11-15 | — | — | US | disclosed |
| US-4033860-A | Mercaptan conversion process | UOP INC. (US) | 1977-07-05 | — | — | US | disclosed |
| US-4032686-A | ARTICLES COATED WITH A CURED COMPOSITION OF HYDROXY(POLYALKYLENECARBONYLOXY)ALKYLENEOXAZOLIDINE AND A POLYISOCYANATE | ROHM AND HAAS COMPANY (US) | 1977-06-28 | — | — | US | disclosed |
| US-4024117-A | HYDROXY-ALKYLENE-OXAZOLIDINE, ISOCYANATE | ROHM AND HAAS COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-4003827-A | DOCTOR TREATMENT | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1977-01-18 | — | — | US | disclosed |
| US-3978137-A | OXIDATION OF SULFUR-CONTAINING COMPOUNDS | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336856-B2 | Alkoxysilane- and allophanate-functionalized coating materials | DDAH1, OR10J3, AP3S1 | TSHR 4762/4885NFKB1 3330/4885KCNA1 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.